The novel function of citronellal for antidiabetic cardiomyopathy

Acta Biochim Biophys Sin (Shanghai). 2021 Dec 8;53(12):1731-1735. doi: 10.1093/abbs/gmab138.
No abstract available

MeSH terms

  • Acyclic Monoterpenes / pharmacology*
  • Acyclic Monoterpenes / therapeutic use
  • Aldehydes / pharmacology*
  • Aldehydes / therapeutic use
  • Animals
  • Cardiovascular Agents / pharmacology*
  • Cardiovascular Agents / therapeutic use
  • Diabetic Cardiomyopathies / complications
  • Diabetic Cardiomyopathies / metabolism
  • Diabetic Cardiomyopathies / pathology
  • Diabetic Cardiomyopathies / prevention & control*
  • Fibrosis / metabolism
  • Heart Failure / complications
  • Heart Failure / prevention & control
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Vascular Endothelial Growth Factor Receptor-1 / genetics
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism
  • Ventricular Dysfunction, Left / complications
  • Ventricular Dysfunction, Left / metabolism
  • Ventricular Dysfunction, Left / pathology
  • Ventricular Dysfunction, Left / prevention & control

Substances

  • Acyclic Monoterpenes
  • Aldehydes
  • Cardiovascular Agents
  • Vascular Endothelial Growth Factor Receptor-1
  • citronellal